Philadelphia Chromosome Negative Bcr-abl1 Positive Chronic Myelogenous Leukemia

• CLINICAL_TRIALS trial_result · 2021-02-02
  Clinical Trial Update: Sorafenib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia [Phase 1, Phase 2]

  Phase 1/2 clinical trial evaluating sorafenib in pediatric patients with relapsed or refractory solid tumors or leukemia; results completed …